×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Systemic Infection and Tau Pathology Acceleration
mechanism
1,563 words
KG: Systemic Infection and Tau Pathology Acceleration
2026-03-28
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
Systemic Infection and Tau Pathology Acceleration
⚙
Mechanism Info
Name
Systemic Infection and Tau Pathology Acceleration
Summary
Mechanism page covering how acute systemic infections (pneumonia, UTIs) accelerate tau pathology and dementia via neuroinflammation and cytokine-mediated pathways
Knowledge Graph
Related Hypotheses (26)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Aquaporin-4 Polarization Rescue
Score: 0.51
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.47
APOE Isoform Conversion Therapy
Score: 0.44
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
Correcting Gut Microbial Dopamine Imbalance to Support Syste
Score: 0.41
Show 21 more
Related Analyses (30)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (3)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Mouse Cdk5, p35, and p39 mutations in neuronal migration
validation · proposed · Score: 0.80
See Also (15)
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegene
therapeutic · Pages share 5 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 5 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 5 hypotheses
Section 217 Advanced Cell Therapy and Regenerative Medi
therapeutic · Pages share 5 hypotheses
Section 187: Advanced Cytokine and Chemokine Network Th
therapeutic · Pages share 5 hypotheses
Advanced Neuroimmune Interface and Glial-Neuronal Cross
therapeutic · Pages share 5 hypotheses
Section 147 Neuroimmune Interface and Glial-Neuronal Cr
therapeutic · Pages share 5 hypotheses
RIPK1 Inhibitors for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Precision Medicine Approaches for Neurodegeneration
therapeutic · Pages share 5 hypotheses
P2X7 Receptor Antagonists for Neurodegeneration
therapeutic · Pages share 5 hypotheses
nfat-pathway-modulators-neurodegeneration
therapeutic · Pages share 5 hypotheses
Show 10 more